LncRNA CDKN2B-AS1 acts as a ceRNA and binds to miR-181a-5p, reversing the inhibitory effect of miR-181a-5p on TGFβI, leading to malignant progression of cervical cancer [33]. This evidence concerns the gene CDKN2B and cervical carcinoma.